Michael W. Dunne - 25 Mar 2022 Form 4 Insider Report for Iterum Therapeutics plc (ITRM)

Role: Director
Signature: /s/ Michael W. Dunne
Issuer symbol: ITRM
Transactions as of: 25 Mar 2022
Net transactions value: $0
Form type: 4
Filing time: 29 Mar 2022, 20:00:14 UTC
Previous filing: 27 Jul 2021
Next filing: 17 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ITRM	Ordinary Shares	Options Exercise	$0	+10,494	+3.1%	$0.000000	346,849	25 Mar 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ITRM	Restricted Share Units	Options Exercise	$0	-10,494	-100%	$0.000000^*	0	25 Mar 2022	Ordinary Shares	10,494		Direct	F1, F2
transaction	ITRM	Restricted Share Units	Award	$0	+11,426		$0.000000	11,426	25 Mar 2022	Ordinary Shares	11,426		Direct	F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted share units ("2021 RSUs") converted into ordinary shares on a one-for-one basis upon vesting of the 2021 RSUs.
F2	On March 25, 2021, the reporting person was granted an award of 10,494 2021 RSUs, which vested on March 25, 2022.
F3	Each restricted share unit ("2022 RSU") represents the contingent right to receive one ordinary share upon vesting of a 2022 RSU.
F4	Subject to the reporting person providing continuous service to the Issuer and the other terms and conditions of the Issuer's 2018 Amended and Restated Equity Incentive Plan, as amended, the 2022 RSUs shall vest in full on January 1, 2023.